Insight Molecular Diagnostics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell IMDX and other ETFs, options, and stocks.About IMDX
Insight Molecular Diagnostics, Inc. is a molecular diagnostics company, which engages in the development and commercialization of diagnostic tests for the detection of cancer, including molecular diagnostic services to pharmaceutical customers. Its products include DetermaRx and DetermaIO.
CEOJoshua Riggs
CEOJoshua Riggs
Employees49
Employees49
HeadquartersNashville, Tennessee
HeadquartersNashville, Tennessee
Founded2009
Founded2009
Employees49
Employees49
IMDX Key Statistics
Market cap188.04M
Market cap188.04M
Price-Earnings ratio-2.34
Price-Earnings ratio-2.34
Dividend yield—
Dividend yield—
Average volume42.23K
Average volume42.23K
High today$7.10
High today$7.10
Low today$6.47
Low today$6.47
Open price$6.61
Open price$6.61
Volume50.82K
Volume50.82K
52 Week high$8.51
52 Week high$8.51
52 Week low$1.92
52 Week low$1.92
Stock Snapshot
With a market cap of 188.04M, Insight Molecular Diagnostics(IMDX) trades at $6.64. The stock has a price-to-earnings ratio of -2.34.
As of 2026-01-19, Insight Molecular Diagnostics(IMDX) stock has fluctuated between $6.47 and $7.10. The current price stands at $6.64, placing the stock +2.6% above today's low and -6.5% off the high.
The Insight Molecular Diagnostics(IMDX)'s current trading volume is 50.82K, compared to an average daily volume of 42.23K.
During the past year, Insight Molecular Diagnostics(IMDX) stock moved between $1.92 at its lowest and $8.51 at its peak.
During the past year, Insight Molecular Diagnostics(IMDX) stock moved between $1.92 at its lowest and $8.51 at its peak.
People also own
Based on the portfolios of people who own IMDX. This list is generated using Robinhood data, and it’s not a recommendation.